Stockreport

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis [Yahoo! Finance]

Organogenesis Holdings Inc. - Class A  (ORGO) 
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm Check Earnings Report
PDF Transformational opportunity for Organogenesis to enter large and growing pain management market with innovative therapy Will address critical unmet medical need for [Read more]